Literature DB >> 2441020

The effect of molecular size on the nasal absorption of water-soluble compounds in the albino rat.

A N Fisher, K Brown, S S Davis, G D Parr, D A Smith.   

Abstract

The nasal absorption of a range of water-soluble compounds with different molecular weights, 4-oxo-4H-1-benzopyran-2-carboxylic acid (mol. wt 190), p-aminohippuric acid (mol. wt 194), inulin (mol. wt 5200) and dextran (mol. wt 70,000), has been investigated in the male Wistar rat. Compounds were instilled into the nasal cavities of anaesthetized animals, and for comparison, similar doses were administered intravenously. Serial samples of bile and urine were collected for up to 6 h. Nasal absorption, estimated by comparison of the extent of excretion in bile and urine following intranasal and intravenous administration, was 100% for 4-oxo-4H-1-benzopyran-2-carboxylic acid (1 mg kg-1), 75% for p-aminohippuric acid (1 mg kg-1), 15% for inulin (0.1 mg kg-1) and 2.8% for dextran (0.25 mg kg-1). The log molecular weight gave a good linear correlation with the log per cent intranasally absorbed (correlation coefficient of -0.996). From the molecular weight relationship, these data infer aqueous channel mechanisms for the nasal absorption of water-soluble compounds.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441020     DOI: 10.1111/j.2042-7158.1987.tb03398.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  The molecular weight dependence of nasal absorption: the effect of absorption enhancers.

Authors:  M D Donovan; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Nasal route and drug delivery systems.

Authors:  Selcan Türker; Erten Onur; Yekta Ozer
Journal:  Pharm World Sci       Date:  2004-06

Review 3.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

4.  Nasal absorption of hydroxocobalamin in healthy elderly adults.

Authors:  D Z van Asselt; F W Merkus; F G Russel; W H Hoefnagels
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

5.  Drug absorption through mucosal membranes: effect of mucosal route and penetrant hydrophilicity.

Authors:  D C Corbo; J C Liu; Y W Chien
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

6.  Nasal absorption enhancers for biosynthetic human growth hormone in rats.

Authors:  D T O'Hagan; H Critchley; N F Farraj; A N Fisher; B R Johansen; S S Davis; L Illum
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

7.  Permeability of peptides and proteins in human cultured alveolar A549 cell monolayer.

Authors:  S Kobayashi; S Kondo; K Juni
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

8.  Insoluble powder formulation as an effective nasal drug delivery system.

Authors:  Fusashi Ishikawa; Mika Murano; Minoru Hiraishi; Toshikazu Yamaguchi; Ikumi Tamai; Akira Tsuji
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

9.  Intranasal administration of oxytocin: behavioral and clinical effects, a review.

Authors:  Jan G Veening; Berend Olivier
Journal:  Neurosci Biobehav Rev       Date:  2013-05-04       Impact factor: 8.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.